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Introduction
Scientific research has identified potential health benefits of many food ingredients. These healthpromoting (bioactive) food ingredients may be naturally present in a food, or may be added by
manufacturers into foods that do not naturally contain such components. These bioactives have
challenged traditional concepts of food fortification and consequently food regulations. Dairy foods
and ingredients have significant potential as vehicles for the delivery of such bioactives and healthpromoting physiological effects, if regulatory hurdles can be overcome.
Food regulations and standards differ significantly between countries, and across larger
jurisdictional organizations (e.g. Codex Alimentarius, USA Food and Drug Administration) but
generally, before a “new” food can be placed on the market, specific authorization will need to be
obtained from the relevant regulator. The process of authorization will depend on whether the food
or ingredient is regarded as new, novel, traditional or non-traditional (i.e. does not have a significant
history of consumption in that market).
The requirements for food labelling and the substantiation of health claims are currently being
debated by regulatory authorities and food manufacturers world-wide. The regulatory landscape on
the addition of bioactive ingredients into foods is rapidly evolving and this paper will provide an
overview of the challenges facing food manufacturers. The information in this paper not only
applies to dairy foods, but also applies to functional ingredients sourced from dairy processing
streams for addition to non-dairy foods.
Dairy Foods
Milk is a major provider of important nutrients for humans, including calcium, protein and
riboflavin, however, it is now recognised that dairy products and ingredients derived from milk and
whey can provide functional food products with beneficial effects on human health, as well as
nutritional benefits. Casein and whey proteins and their derivatives have been shown to possess
biological activities, including peptides able to exert anti-hypertensive and other bioactive effects,
lactoferrin and lactoperoxidase able to exert anti-microbial effects, and growth factors used in sports
health and for tissue repair applications including wound repair (Playne et al. 2003). The currently
identified bioactive components in bovine milk or colostrum, their physiological activities and their
concentration in bovine milk have recently been reviewed (Rowan et al. 2005).
Probiotics comprise approximately 65% of the world functional food market. Probiotic products
have been reported to improve and maintain intestinal microflora, protect against infections,
alleviate lactose intolerance, reduce blood cholesterol levels and also stimulate the immune system
(Holzapfel and Schillinger, 2002). The physiological effects of probiotics can occur through either
the direct effect of the live microbial cells, known as the probiotic effect, or indirectly via the
metabolites produced by these cells which is referred to as the biogenic effect. Dairy products such
as cheese have been shown to be an excellent delivery vehicle for probiotics and biogenic
substances (Hayes et al. 2006) and for a variety of naturally-occurring health-promoting
components such as conjugated linoleic acid (CLA) and omega-3 fatty acids (McIntosh et al. 2006).
Peptides can be released by enzymatic proteolysis of food proteins and may act as potential
physiological modulators of metabolism during the intestinal digestion of the diet. The possible
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physiological effects of peptides relate to nutrient uptake, immune defence, opioid and
antihypertensive activities. Milk proteins, especially caseins, are an important source of these
bioactive peptides. During recent years, major whey protein components, alpha-lactalbumin and
beta-lactoglobulin have also been shown to contain bioactive sequences. Peptides showing opioid
and angiotensin I-converting enzyme (ACE) inhibitory activity have been found in alphalactalbumin and beta-lactoglobulin. Opioid peptides, alpha-lactorphin and beta-lactorphin, have
been liberated during in vitro proteolysis of bovine whey proteins, and pharmacological activity was
observed at micromolar concentrations. Whey hydrolysates showed ACE-inhibitory activity after
proteolysis with different digestive enzymes, and several active peptides were identified. The results
demonstrated the existence of several biologically active whey-derived peptides and hydrolysates
(Pihlanto-Leppala, 2000).
An issue of concern to the dairy industry relates to recent regulations on the labelling of foods with
respect to the level of trans fatty acids (TFA). With the scientific evidence associating trans fatty
acid intake with an increased risk of coronary heart disease (CHD), the USA Food and Drug
Administration (FDA) has issued a rule that requires the declaration of the amount of TFA present
in foods, including dietary supplements, on the nutrition label from January 1, 2006. For the purpose
of nutrition labelling, TFA are defined as the sum of all unsaturated fatty acids that contain one or
more isolated (i.e. non-conjugated) double bonds in a trans configuration. There are many issues that
the FDA has yet to resolve: (1) defining nutrient content claims for "free" and "reduced" levels of
trans fat, (2) placing limits on the amount of TFA in conjunction with saturated fat limits for nutrient
content claims, health claims, and disclosure and disqualifying levels, (3) a daily value, and (4) a
possible footnote or disclosure statement to enhance consumer understanding of cholesterol raising
lipids. The FDA will be conducting consumer research to determine consumer understanding of
various TFA labelling possibilities (Moss, 2006). Researchers (Lock et al. 2005) and the
International Dairy Federation (IDF) are attempting to differentiate certain health-promoting dairyderived trans fats (such as CLA) from the industrially-produced hydrogenated trans fats that have
been reported to result in an increased risk of CHD.
Functional foods promise to deliver health and wellness to consumers in an environment where
lifestyle diseases and an ageing population are threatening the wellness of society. Milk is a natural,
multi-component, nutrient-rich beverage. Market trends indicate that milk-based beverages are ideal
vehicles for newly discovered bioactive food ingredients targeting lifestyle diseases. Low-fat milk
and drinking yogurt are the most commonly used vehicles for the delivery of bioactive food
ingredients. Among the recent trends, low-fat milk is commonly used for delivery of omega-3 fatty
acids, while probiotic yogurt drinks are preferred for the delivery of plant sterols. Drinks containing
combinations of dairy and fruit juices with added bioactive components are also becoming common
in the USA and European Union (EU) markets. Although a range of bioactive components is
available for incorporation into dairy beverages, there are significant formulation challenges.
Experience indicates that consumers will not buy food products that imply they are sick. Therefore,
functional foods should be promoted as convenient, nutritious and tasty formulations with specific
health benefits (Sharma, 2005).
Dairy foods with added functional ingredients or non-dairy foods with added dairy ingredients may
be considered by regulatory authorities to be “novel” or “non-traditional” foods i.e. foods that do not
have a significant history of human consumption. Such foods may raise human safety concerns and
will likely need to undergo a risk-based assessment before being allowed into the food supply
(Healy, 2003). Production of standard dairy products can also have its challenges in some parts of
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the world with strict regulations in place regarding pesticides and antibiotics in milk (Heeschen and
Suhren, 1993).
Health Claims
The assessment of scientific safety and efficacy of a food or ingredient by the relevant regulatory
authority is likely to require data on the characterization and source of the ingredient, manufacturing
processes, concentration in the food product, and related safety considerations. The evidence for
confirmation of efficacy may include in-vitro data, in vivo animal trials using levels of defined
biomarkers as measures of a physiological effect, but more than one human intervention trials in
different population groups is also likely to be essential. Evaluations will probably include a number
of quality criteria such as the quality of the study design, conduct and analysis and decisions will
need to be based on the totality of the evidence. In the future, regulators may also require research to
test how consumers are likely to interpret and use any health claim.
Consumers' main scepticism regarding functional foods resides in the veracity of health claims and
in the often inadequate control of their claimed properties. Legislation concerning this matter is
progressing at a slow pace and currently only Japan, the UK, USA, Canada, the Netherlands and
some Scandinavian countries have managed to make notable progress. It is anticipated that
technological advances in the food industry, in conjunction with extensive clinical trials and
governmental control, will eventually guarantee the credibility of health claims and ensure
consumers' confidence in functional foods (Arvanitoyannis and Van Houwelingen-Koukaliaroglou,
2005).
Functional foods can be considered to be those whole, fortified, enriched or enhanced foods that
provide health benefits beyond the provision of essential nutrients (e.g., vitamins and minerals),
when they are consumed at efficacious levels as part of a varied diet on a regular basis. Linking the
consumption of functional foods or food ingredients with health claims should be based on sound
scientific evidence, with the "gold standard" being replicated, randomized, placebo-controlled,
intervention trials in human subjects. However, not all foods on the market today that are claimed to
be functional foods are supported by enough solid data to merit such claims (Hasler, 2002).
In a recent study of television food advertisements in the USA, 14.9% made a weight-related
nutritional claim. The authors concluded that practitioners and policy makers should be aware of the
prevalence of food advertisements and their potential impact on knowledge and behaviour and
should consider working more closely with food manufacturers to encourage the creation and
promotion of weight-friendly foods. Furthermore, it was suggested that nutrition educators could
help by teaching consumers critical thinking skills that may relate to food advertisements
(Henderson and Kelly, 2005). Similar conclusions were reached in a study of food advertisements in
a series of women’s magazines (Hickman et al. 1993).
A cautionary note with respect to making less than fully-substantiated claims for foods lies in the
recent litigation brought by a group of overweight children against the McDonald's Corporation that
seeks compensation for obesity-related health problems. While many derided this lawsuit as
representing the worst excesses of the tort liability system, others have drawn parallels to tobacco
litigation. Food-related litigation raises the question of where accountability for the economic and
public health consequences of food-related disorders properly rests (Mello et al. 2003).
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A view has been expressed that the ethical responsibility for marketing sound health messages for
dairy products rests with the industry. Although there are regulatory processes in place to protect the
consumer, these can sometimes be circumvented. Making a health claim requires a certain level of
proof for it to be accepted, and the food industry should strive to meet these challenges.
Consideration must also be given to potential negative effects, such as the denigration of the product
category, by the use of unsubstantiated health claims which may mislead the consumer (MacNeill,
2003). Consumers often express concern that health claims are just another sales tool, and the use of
poorly substantiated claims could increase the current levels of consumer scepticism about all
attempts to communicate the health benefits of food (Health Canada, 2000; Food Standards Agency,
2004).
Communication of Health Claims to Consumers
Food labels are an important educational tool to assist consumers in making healthy food choices. In
addition to mandatory nutritional labelling information, manufacturers have a variety of options on
the food/supplement packages to communicate the nutrition/health benefits of their products
(Agarwal et al. 2006).
Dairy foods have long been promoted using health messages. People wanting to improve public
health have promoted dairy foods, and people promoting dairy foods have used health messages.
Health messages that have been used and are relevant for the promotion of dairy foods include
nutrient content messages, low-fat messages and health claims. The changes in legislation
permitting the use of (some) health claims on food labels and in advertisements aimed at consumers
will expand the repertoire of messages available to communicate the benefits of dairy foods.
However, health claims will not replace nutrient content and low-fat messages, and all three types of
health messages are likely to be widely used to promote dairy foods in the future (Lawrence, 2005).
It is very important that health claims on food products can be understood by the consumer.
However, there is no clear understanding of how consumers use health claims and their likely
impact on consumer food behaviour or health. More research is needed, but a review of previous
studies allows some common conclusions to be drawn. Health claims on foods are seen by
consumers as useful, and when a product features a health claim they view it as healthier and state
they are more likely to purchase it. Consumers are sceptical of health claims from food companies
and strongly agree that they should be approved by government. Consumers do not make clear
distinctions between nutrition content claims, structure-function claims and health claims. They
generally do not like long and complex, scientifically worded claims on foods; they prefer split
claims - with a short succinct statement of the claim on the front of pack and more detail provided
elsewhere (Williams, 2005a). There is also some evidence that the use of health claims improves the
quality of dietary choices and knowledge of diet-disease relationships (Williams, 2005b).
An aim of the FDA food labelling regulations is to ensure that manufacturers aid consumers in
making choices regarding their diets by eliminating ''hollow'' health claims. Of particular concern
are health claims made by one brand when the claim is inherent to the product category but has not
been featured previously in advertisements or on packaging. There is concern that consumers will
use information provided by one brand about such an attribute to infer that the other brands in the
product category do not possess the attribute and thus be misled. Results from three experiments
show that this practice can mislead consumers and affect consumer inferences, use of the target
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attribute, and choice in favour of the brands displaying the attribute. Furthermore, it was shown that
improved consumer education can be achieved without the deception associated with narrow (brandspecific) health claims by using broader (category-defined) claims. Finally, it was shown that an
incentive should remain for manufacturers to use broader claims whenever consumers are likely to
be choosing between alternatives from broadly defined product categories (e.g. cooking oils versus
peanut oils) (Burke et al. 1997).
A study of consumers (n = 958) has been carried out to evaluate whether product-related health
claims in foods are either advantageous or disadvantageous. Claims were made for six functional
components and two control products. In general, all claims were perceived as neutral or as
advantageous. Increasing the strength of the claim did not automatically increase the perceived
benefit. Gender, trust in different information sources and the frequency of use of so-called
functional foods affected the perceived benefit. Women perceived the claims to be more beneficial
than did men. Trustful respondents perceived the claims as more advantageous than did sceptical
respondents, and the users of functional foods perceived health claims to be more advantageous than
did non-users. In addition, personal motivation affected the perception of the claims. With less
familiar functional components, the strength of the claim increased the perceived benefit, whereas
with familiar components, claims mentioning the reduced risk or prevention of a disease did not
increase the perceived advantage (Urala et al. 2003).
A subsequent study by the same group quantified the attitudes behind consumers' willingness to use
these products. Functional food-related statements formed seven factors describing consumers'
attitudes towards functional foods. These factors were: perceived reward from using functional
foods, confidence in functional foods, necessity for functional foods, functional foods as medicines,
absence of nutritional risks in functional foods, functional foods as part of a healthy diet and the
health effects of functional foods versus their taste. These attitude subscales differentiated between
consumers (n = 1158) in their reported willingness to use functional foods. The best predictor for
willingness to use functional foods was the perceived reward (Urala and Lahteenmaki, 2004).
One dilemma with health claims is that too much information can confuse consumers and too little
information can mislead them. A controlled study has been used to examine the effectiveness of
various front-sided health claims when used in combination with a full health claim on the back of a
package. The results indicated that combining short health claims on the front of a package with full
health claims on the back of the package leads consumers to more fully process and believe the
claim (Wansink, 2003).
A similar approach has recently been used in a recent study comparing claims about reduced risk of
osteoporosis on milk or a calcium-fortified orange juice. It investigated whether splitting a claim (a
brief claim at the front of a package directing consumers to the full health claim at the back), and/or
endorsement of the claim (by a regulatory body), have affected the acceptance of the claim by the
consumer. Participants recruited by a shopping mall intercept method were interviewed face-to-face
using a questionnaire. Split health claims produced more positive responses than not-split claims in
several areas: they created a higher level of satisfaction with the labelling, they produced a higher
level of trust, and they communicated better the health risk on the claim. Endorsement of the claim
did not influence responses, possibly because of the small print of the approval statement or low
awareness of the regulatory body among consumers, but belief in the claim was significantly higher
on the milk product compared to the juice (Singer et al. 2006).
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Foods for Specified Health Uses (FOSHU)
In 1993, the Ministry of Health and Welfare in Japan established a policy of "Foods for Specified
Health Uses" (FOSHU) by which health claims of some selected functional foods are legally
permitted. Since the time (1984) when the concept of "functional food" was proposed, it appears that
the science in Japan has been progressing, among others, along a unique path of development. The
uniqueness is seen in the development of functional foods by minimizing undesirable as well as
maximizing desirable food factors, for example, hypoallergenic foods, developed from their
materials by removing allergens (Arai, 2000).
Terms such as 'nutraceuticals' and 'dietary or food supplements' are not well recognised in Japan
compared to many other countries. However, the concept of 'functional foods' is well known as a
result of research studies initiated on the health benefits of foods in 1984. The Ministry of Education
organized a national research and development project to evaluate the functionalities of various
foods. Researchers from diverse scientific fields defined new functions of food, successfully
incorporating the previously recognized functions of nutrition, sensory/satisfaction and
physiological effects of ingredients in foods. Some food manufacturers and distributors
unfortunately capitalized on such food functionalities to promote 'health foods' by claiming druglike effects and violating laws. In 1991, the Ministry of Health and Welfare (MHW) now as the
Ministry of Health, Labor and Welfare (MHLW) introduced a 'foods for specified health uses'
(FOSHU) system, for the control of such exaggerated and misleading claims. The other reason for
such enforcement was due to an increase in the population of elderly people and lifestyle-related
diseases that include obesity, diabetes mellitus, high blood pressure, cerebro- and cardiovascular
diseases and cancer. In 2001, a new regulatory system, 'foods with health claims' (FHC) with a
'foods with nutrient function claims' (FNFC) system and newly established FOSHU was introduced.
In addition, the MHLW changed the existing FOSHU, FNFC and other systems in 2005. Such
changes include the new Subsystems of FOSHU such as (1) standardized FOSHU, (2) qualified
FOSHU and (3) disease risk reduction claims for FOSHU (Ohama et al. 2006).
The regulatory range of FOSHU was broadened in 2001 to accept capsules and tablets in addition to
conventional foods. The MHLW enacted a new regulatory system, 'Foods with Health Claims', in
April 2001, which consists of the existing FOSHU system and the newly established 'Foods with
Nutrient Function Claims' (FNFC). Under the FNFC, twelve vitamins (vitamins A, B-1, B-2, B-6,
B-12, C, E, D, biotin, pantothenic acid, folic acid, and niacin) and two minerals (Ca and Fe) were
standardized. Examples of claims regarding these substances include: 'Calcium is a nutrient which is
necessary to form bones and teeth'; 'Vitamin D is a nutrient which promotes calcium absorption in
the gut intestine and aids in the formation of bones'. The upper and lower levels of the daily
consumption of these nutrients are also determined. The labelling of functional foods should be
based on scientific evidence and be in harmony with international standards. The nutrient-function
claim was adopted in the guidelines for nutrition claims by the Codex Alimentarius in 1997. The
claims of the Japanese FNFC are equivalent to the nutrient function claims standardized by the
Codex Alimentarius. The enhanced function claim and the disease risk-reduction claims were
proposed by both the Codex Alimentarius and an Economic Union project in 1999. The structure
function claim, which is similar to the enhanced function claim, was enacted by the Dietary
Supplement Health and Education Act in the USA in 1994. Most of the statements of the Japanese
FOSHU system are close to the structure/function claims in the USA or the enhanced function
claims of the Codex Alimentarius (Shimizu, 2003).
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Codex Alimentarius
The Codex Alimentarius (Latin = “food law” or “food code”) is a collection of internationally
recognized standards, codes of practice, guidelines and other recommendations relating to foods,
food production and food safety under the aegis of consumer protection. Officially, it is maintained
by the Codex Alimentarius Commission, a body established jointly by the Food and Agriculture
Organization of the United Nations (FAO), and the World Health Organization (WHO) in 1963 to
protect the health of consumers and ensure fair practices in international food trade.
The Codex Alimentarius position is that health claims should be permitted provided that all of the
following conditions are met:
•

Health claims must be based on current relevant scientific substantiation and the level of proof
must be sufficient to substantiate the type of claimed effect and the relationship to health as
recognised by generally accepted scientific review of the data and the scientific substantiation
should be reviewed as new knowledge becomes available. The health claim must consist of two
parts:
(i)
(ii)

Information on the physiological role of the nutrient or on an accepted diet-health
relationship; followed by
Information on the composition of the product relevant to the physiological role of
the nutrient or the accepted diet-health relationship unless the relationship is based on
a whole food or foods whereby the research does not link to specific constituents of
the food.

•

Any health claim must be accepted by or be acceptable to the competent authorities of the
country where the product is sold.

•

The claimed benefit should arise from the consumption of a reasonable quantity of the food or
food constituent in the context of a healthy diet.

•

If the claimed benefit is attributed to a constituent in the food, for which a Nutrient Reference
value is established, the food in question should be:
(i)
(ii)

•

A source of or high in the constituent in the case where increased consumption is
recommended, or,
Low in, reduced in, or free of the constituent in the case where reduced consumption
is recommended. Where applicable, the conditions for nutrient content claims and
comparative claims will be used to determine the levels for “high”, “low”, “reduced”,
and “free”.

Health claims should have a clear regulatory framework for qualifying and/or disqualifying
conditions for eligibility to use the specific claim, including the ability of competent national
authorities to prohibit claims made for foods that contain nutrients or constituents in amounts
that increase the risk of disease or an adverse health-related condition. The health claim should
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not be made if it encourages or condones excessive consumption of any food or disparages good
dietary practice.
•

If the claimed effect is attributed to a constituent of the food, there must be a validated method
to quantify the food constituent that forms the basis of the claim.

•

The following information should appear on the label or labelling of the food bearing health
claims:
- A statement of the quantity of any nutrient or other constituent of the food that is the
subject of the claim.
- The target group, if appropriate.
- How to use the food to obtain the claimed benefit and other lifestyle factors or other dietary
sources, where appropriate.
- If appropriate, advice to vulnerable groups on how to use the food and to groups, if any,
who need to avoid the food.
- Maximum safe intake of the food or constituent where necessary.
- How the food or food constituent fits within the context of the total diet.
- A statement on the importance of maintaining a healthy diet.

Process for the Assessment of Scientific Support for Claims on Foods (PASSCLAIM)
The European Commission concerted action PASSCLAIM aimed to produce a generic tool for
assessing the scientific support for health-related claims for foods and food components (Prentice et
al. 2003). Much attention is now being paid to claims for foods, especially those related to the
newly discovered effects of dietary components on body functions. The main thrust of the recent
Consensus Document on Scientific Concepts of Functional Foods in Europe, produced as the final
deliverable from the EU DG XII Functional Food Science in Europe (FUFOSE) Concerted Action,
was to suggest the outline of a scheme to link claims for functional foods to solid scientific
evidence. FUFOSE suggested that Claims for "enhanced function" and "reduced risk of disease" are
only justifiable when they are based on appropriate, validated markers of exposure, enhanced
function or reduction of disease risk.
The PASSCLAIM project built upon the principles defined within the publications arising out of the
FUFOSE project and ran from 2001 to 2005.
The objectives of PASSCLAIM were:
•

To produce a generic tool with principles for assessing the scientific support for healthrelated claims for foods and food components which are eatable or drinkable.

•

To critically evaluate the existing schemes which assess the scientific substantiation of
claims, and

•

To select common criteria for how markers should be identified, validated and used in welldesigned studies to explore the links between diet and health.
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The criteria for the scientific substantiation of health claims on foods have been defined by the
PASSCLAIM project and are as follows:
•

The food or food component to which the claimed effect is attributed should be
characterised.

•

Substantiation of a claim should be based on human data, primarily from intervention
studies.

•

When the true endpoint of a claimed benefit cannot be measured directly, studies should use
markers.

•

Markers should be biologically valid (i.e. they should have a known relationship to the final
outcome), and be methodologically valid with respect to their analytical characteristics.

•

Within a study, the target variable should change in a statistically significant way

•

A claim should be scientifically substantiated by taking into account the totality of the
available data and by weighing up of the evidence.

Potential health claims can be based not only on modifications of target body functions (for obesity:
body fat deposition), but also on other relevant associated functions (for obesity: energy intake,
energy expenditure and fat storage) and should be evaluated by valid methodologies. According to
the PASSCLAIM consensus document, the substantiation of health claims should take into account
the totality of the available data, however it should be based on human data, primarily from
intervention studies with an appropriate design and a relevant end-point (Riccardi and Giacco,
2005).
Several approaches to the use of health claims on foods have been made around the world, and the
common theme is that any health claim will require scientific validation and substantiation. There is
also broad consensus that any regulatory framework should protect the consumer, promote fair trade
and encourage innovation in the food industry. There is a need to have uniform understanding,
terminology and description of types of nutrition and health claims. Two broad categories have been
defined within PASSCLAIM: Nutrition Claims, i.e. what the product contains, and Health Claims,
i.e. relating to health, well-being and/or performance, including well-established nutrient function
claims, enhanced function claims and disease risk reduction claims (Richardson et al. 2003).
USA Food and Drug Administration (FDA)
The USA Food and Drug Administration's regulatory authority over health claims was clarified in
1990 legislation known as the Nutrition Labelling and Education Act (NLEA). This law established
mandatory nutrition labelling for most foods and placed restrictions on the use of food label claims
characterizing the levels or health benefits of nutrients in foods. NLEA set a high threshold for the
scientific standard under which the FDA may authorize health claims, this standard is known as the
significant scientific agreement (SSA) standard. Subsequent legislation known as the FDA
Modernization Act (FDAMA) provided an alternative to FDA review of a health claim where a
USA government scientific body other than FDA, concluded that there is SSA for a
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substance/disease relationship. Courts have since extended the scope of health claims to include
qualified health claims (QHC) that are health claims not substantiated on evidence that meets the
level of SSA standard, but include a qualifying statement intended to convey to the consumer the
level of evidence for the claim. FDA has responded by developing an evidence-based ranking
system for scientific data to determine the level of evidence substantiating a health claim, and a
established a system with four different levels of substantiation (Rowlands and Hoadley, 2006).
However, it appears consumers are confused by the system of qualified health claims. They find it
difficult to understand the meaning of the different types of qualified claims and may even interpret
the qualification levels to refer to the overall safety of the product rather than an evaluation of the
strength of the scientific substantiation (IFIC, 2005).
The USA Congress through the Nutrition Labeling and Education Act of 1990 authorized the use of
health claims on food labels. These claims describe the relationship between a substance and a
disease or health-related condition. In addition, Congress directed the U.S. FDA to apply a
significant scientific agreement standard in approving these claims. Since 1990, the FDA has
approved several health claims, but has also denied claims that did not meet this standard. The
purpose of The Nutrient Disease Relationships: Closing the Scientific Knowledge Gap symposium
was to provide researchers with perspectives to keep in mind when designing studies that examine
the relationship between a nutrient and a disease or health-related condition, to help close the
scientific knowledge gap for nutrient-disease relationships of scientific, consumer, and public health
interest (Saldanha and Johnson, 2005).
Generally Recognized As Safe (GRAS) Status
The FDA in the USA had set the bar too high for health claims and was forced by the courts to
implement a more reasonable standard, but the response, Qualified Health Claims, has failed to gain
the confidence of the public because of the confusing wording of the claims demanded by FDA. The
Dietary Supplement Health and Education Act (DSHEA) was the product of a compromise with a
lower threshold for demonstration of safety (reasonable expectation of no harm) that would be met
by consumer self-policing and assumption of some risk. FDA has thwarted this effort by raising the
bar for New Dietary Ingredient Notifications (NDIN) to what appears to be the higher threshold for
the safety of food ingredients (reasonable certainty of no harm) - FDA apparently sees these two
safety thresholds as a distinction without a difference. As a result, increasing numbers of dietary
supplement manufacturers, unwilling to gamble the future of their products to a system that provides
little hope for the FDA's response of "no objection", have committed the additional resources
necessary to obtain Generally Recognized As Safe (GRAS) status for their supplements. The
pressure on FDA and Congress for change is again building with increased dissatisfaction among
consumers as the result of confusing labels. A second force for change will be a need to uncouple
the FDA mandated substance-disease relationship and return to the substance-claim relationship to
allow for progress in nutrigenomics and metabolomics, which will result in an increasing number of
substance-biomarker claims (Burdock et al. 2006).
Concluding Remarks
The current intense commercial activity to develop new functional ingredients from dairy products
will continue, and become more sophisticated as knowledge of human physiology and nutrition
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advances, particularly in relation to gastrointestinal microbiology and immunology (Playne et al.
2003).
Collectively, epidemiological, pre-clinical and clinical studies are providing quite compelling
evidence that numerous essential and non-essential dietary components are capable of influencing
growth, development, performance and disease prevention. Scientific discoveries and widespread
interest in the potential medicinal benefits of foods and food components have fostered a variety of
content-, structure function- and health-claims. Unfortunately, defining the ideal diet is complicated
by the numerous and diverse components that may influence biological processes. Inconsistencies in
the literature may reflect the multi-factorial nature of these processes and the specificity that
individual dietary constituents have in modifying genetic and epigenetic events. New and emerging
genomic and proteonomic approaches and technologies offer exciting opportunities for identifying
molecular targets for dietary components and thus determining the mechanisms by which they may
influence the quality of life. It is plausible that bridging knowledge about unique cellular
characteristics with molecular targets for nutrients can be used to develop strategies to optimize
nutrition and minimize disease risk (Milner, 2002).
The development of useful and accurate biomarkers for predicting outcomes of food-based
interventions is becoming more important, given the emphasis being placed on ingredients in foods
contributing to disease risk reduction and optimal health promotion. With the human genome now
identified, opportunities abound to ‘barcode’ individuals with their risk profiles. The increase in
DNA sequence information together with the development of new technologies such as genomics,
proteomics and bioinformatics, has resulted in a much greater capacity to determine individual risk
profiles. Screening for biomarkers at the gene or protein expression level using microarray
technology has the potential to identify new biomarkers for disease diagnosis. Whether these
techniques will enable a better understanding of food-gene interactions to permit health claims
rather than better therapeutic treatment (at high economic cost) remains to be demonstrated
(Roberts, 2002).
While nutrient content claims and general level claims (e.g. calcium and healthy bones) are
allowable in many countries, higher level claims or specific claims relating to disease conditions are
generally not currently allowable by most regulatory bodies worldwide. In contrast to the scientific
substantiation of health claims required by countries such as the USA and Canada, regulations in
China (for example) rely more on long-established and accepted practice and experience developed
in traditional Chinese medicine but have specific requirements with respect to food safety and public
health. A newly agreed to Food Labelling Directive is attempting to harmonise food labelling issues
and health claims across Europe which will result in more stringent levels of scientific
substantiation. However, at the time of writing, the new European nutrition and health claims
regulations have hit an unexpected procedural barrier prior to their expected adoption in September
2006. It is currently unclear whether this barrier will result in a re-visiting of the debate over nutrient
profiling.
In the immediate future, there will very likely be increasing demands on manufacturers in providing
high quality scientific data before approvals for health claims are granted and this may result in
higher consumer confidence in the claims that will appear on food products. However,
manufacturers will also need to consider the time and expense in scientific substantiation / clinical
data to support the claims being sought. In Japan, for example, of the 171 new FOSHU product
approvals in the past 2 years, most were formulated with previously approved functional ingredients.
12

The requirements for food labelling and the substantiation of health claims are currently being
debated by regulatory authorities and food manufacturers world-wide. An advantage that dairy foods
and ingredients have over new/novel foods is that they are generally considered as “traditional”
foods, that is, there is a long history of human consumption, which potentially would allow an easier
path through regulatory approval. Consumer research has also shown that dairy foods such as
yoghurt are viewed as much more credible and appealing carriers of functional ingredients than
indulgent foods such as chocolate (van Kleef et al, 2005). It should be noted that some regulatory
bodies are now including disqualifying criteria for health claims e.g. in the case of addition of a
healthy ingredient into a less-than-healthy food vehicle (e.g. one with a very high sugar content). In
Australia and New Zealand new regulations are being developed to allow the use of approved health
claims. The new system may be finalised by mid 2007, but it is possible that disqualifying nutrient
levels may make it difficult for some dairy foods (eg, high fat cheeses) to be able to carry health
claims. Furthermore, if dairy ingredients are isolated and concentrated and manufacturers are
considering adding such dairy ingredients into other food vehicles, the process for regulatory
approval will still require demonstration of safety and efficacy.
The regulatory landscape on the addition of bioactive ingredients (from dairy streams and non-dairy
sources) into foods is rapidly evolving, and the industry will need to be aware of the potential
regulatory challenges within the countries they wish to market their products.
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